CSPC Pharmaceutical Group Limited (CSPCY) Research

CSPC Pharmaceutical Group Limited, an investment holding entity established in 1992 and headquartered in Shijiazhuang, China, is actively involved in the research, development, manufacturing, and global distribution of pharmaceutical products. Its operations span the People's Republic of China, other Asian markets, the Americas, and Europe. The company organizes its business across three primary divisions: Finished Drugs, Bulk Products, and Functional Food and Others. Its extensive portfolio of finished pharmaceuticals addresses a wide spectrum of medical needs. This includes treatments for neurological disorders such as acute ischemic stroke (NBP), cognitive and memory impairments (Oulaining), and adult idiopathic Parkinson's disease (Enxi). In oncology, CSPC provides medications like Duomeisu for various malignant tumors, including lymphomas and breast cancer, Keaili specifically for breast cancer, and Jinyouli to counteract chemotherapy-induced complications. Cardiovascular health is supported by products like Xuanning for hypertension and Encun to prevent atherosclerotic thrombosis. The company also offers solutions for infections (e.g., Shuluoke, Nuomoling, Weihong, Xinweihong, Qixiao for upper respiratory tract infections), diabetes (Linmeixin, Shuanglexin), and bone health, exemplified by Gubang for postmenopausal osteoporosis. A broad range of pain management and anti-inflammatory medications, including Gaoshunsong, target conditions from arthritis, acute gout, and dysmenorrhea to various musculoskeletal and soft tissue injuries. Additionally, CSPC supplies Debixin for ulcers and Qimaite for acute and chronic pain. Beyond finished drug formulations, the company manufactures essential active pharmaceutical ingredients (APIs) such as antibiotics, vitamin C, and caffeine. It also produces functional food and glucose items and delivers healthcare services. The company adopted its current name, CSPC Pharmaceutical Group Limited, in March 2013, having previously operated as China Pharmaceutical Group Limited.

Open CSPC Pharmaceutical Group Limited (CSPCY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.